(Formerly Jyotirgamya Enterprises Limited) **Atma Industries Limited** (BSE: **539276**) is an Indian listed entity currently undergoing a comprehensive corporate transformation. Historically focused on auto component manufacturing, the company is pivoting toward a diversified trading and consultancy model while simultaneously rectifying significant historical regulatory and operational challenges. --- ### I. Corporate Identity and Strategic Rebranding In **March 2026**, the company received shareholder approval to execute a total rebranding strategy to align its corporate identity with its long-term vision. * **Name Change**: Transitioned from **Jyotirgamya Enterprises Limited** to **Atma Industries Limited**. * **Geographic Shift**: The registered office is relocating from **South Delhi** to the **State of Maharashtra** to better serve its strategic growth objectives. * **Strategic Intent**: The rebranding is designed to enhance market recognition and represent a "new age" corporate philosophy, though the legal obligations and core business rights remain continuous. --- ### II. Diversified Business Portfolio The company operates as a strategic business unit organized by market demand, focusing on high-growth retail and commodity sectors. * **Pharmaceuticals**: Trading of medicinal products with a strategic focus on **Chronic Therapies**, including **Cardiovascular**, **Anti-diabetes**, **Anti-depressants**, and **Anti-cancers**. * **Commodities & Precious Metals**: Trading in **Gold, Metals, and Precious Stones**, subject to national and international price volatility. * **Consumer Goods**: Distribution of **Beauty Products** (personal care/aesthetics) and **Fabrics** (textile materials). * **Business Consultancy**: Providing professional advisory services to external corporate clients. --- ### III. Financial Performance and Capital Structure The company is currently in a state of operational stagnation, reporting **Nil revenue from operations** for the financial years ending **March 31, 2023, 2024, and 2025**. Management attributes this to a broader economic slowdown and the lingering impact of the COVID-19 pandemic. #### **Comparative Financial Summary** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **Rs. Nil** | **Rs. Nil** | **Rs. Nil** | | **Profitability** | **Net Loss** | **Net Loss** | **Net Loss** | | **Paid-up Share Capital** | **Rs. 2,54,74,000** | **Rs. 2,54,74,000** | **Rs. 2,54,74,000** | #### **Capital Composition** * **Authorized Share Capital**: **Rs. 2,80,00,000**. * **Equity Shares**: **23,00,000** shares (Face Value **Rs. 10**). * **Preference Shares**: **2,47,400** (10% Non-Cumulative Compulsorily Redeemable, Face Value **Rs. 10**). * **Buyback History**: No shares have been bought back in the last **five years**. --- ### IV. Capital Management and Liquidity Policy Despite the lack of current revenue, the company maintains a disciplined framework for future capital deployment. * **Gearing Ratio Target**: Management maintains a policy to keep the gearing ratio (Net Debt / Total Capital + Net Debt) between **20% and 40%**. * **Operating Cycle**: Defined as **12 months** for the realization of assets and liabilities. * **Trade Receivables**: Managed on credit terms of **120 to 180 days** (non-interest bearing). * **Borrowing Costs**: Effective interest rate of **9%** on specific borrowings; however, capitalized borrowing costs for the recent period were **INR Nil**. #### **Liquidity Profile (Undiscounted Financial Liabilities)** | Period Ending | On Demand | 3 to 12 Months | Total | | :--- | :--- | :--- | :--- | | **March 31, 2023** | Rs. 0 | **Rs. 40,30,280** | **Rs. 40,30,280** | | **March 31, 2022** | Rs. 0 | **Rs. 41,39,780** | **Rs. 41,39,780** | --- ### V. Governance and Leadership Transitions The company has seen significant shifts in its promoter structure and executive leadership. * **Managing Director**: **Mr. Anil Ganpatlalji Jain** was re-appointed for a **5-year term** in **May 2025**, though he briefly resigned in **September 2025** citing personal reasons before the company's broader restructuring. * **Promoter Reclassification**: * **Jyotirgamya Advisory Private Limited** and **Mr. Saeed UR Rehman** were reclassified to the **'Public' category** in late 2025 (holding **0%**). * Following the demise of promoter **Mrs. Anju Chordia** (who held **5.33%**), the company is updating records to reflect her removal from the Promoter Group per **SEBI (LODR)** regulations. --- ### VI. Risk Framework and Regulatory History Investors should note the company’s history of non-compliance, which led to a **suspension of trading on the BSE** (revoked **May 24, 2024**). #### **Key Risk Factors** * **Regulatory Lapses**: Historical failures include delayed financial reporting (quarters from **Dec 2021 to Dec 2023**), failure to hold the **FY 2022-23 AGM**, and delayed appointment of a **Company Secretary** (appointed **March 20, 2024**). * **Deposit Violations**: A customer advance of **₹24,38,000** from 2020 was improperly classified, violating **Section 73** of the Companies Act. * **Market Volatility**: High sensitivity to **Gold prices** and intense competition in the pharmaceutical and retail sectors. * **Financial Risk Management**: * **Credit Risk**: Managed via a **Receivable Control Management Department**. * **Interest Rate Risk**: Mitigated by holding vehicle borrowings at **fixed rates**. * **Counterparty Risk**: Surplus funds are restricted to **mutual funds** and **risk-free bonds**. --- ### VII. Future Growth Drivers The company’s strategy is predicated on capturing shifts in the Indian macroeconomic landscape: * **Organized Retail**: Capitalizing on the consumption patterns of the "new age" Indian customer. * **Generic Drug Initiatives**: Leveraging government programs for rural health and the introduction of low-cost life-saving drugs. * **Operational Pivot**: Exploring new manufacturing avenues, including a shift toward **casual wear** and textiles to diversify away from the stagnant auto-component legacy.